Cervical Cancer, Endometrial Cancer, Gynecologic Cancer, Ovarian Cancer, Quality of Life, Surgery, Treatment Adherence
Conditions
Brief summary
Patients will be randomized to a unimodal or trimodal prehabilitation program prior to surgery for known or suspected gynecologic cancer.
Detailed description
Prehabilitation generally refers to the act of an intervention prior to a known potentially debilitating event. Usually taking the form of physical therapy prior to surgery, prehabilitation programs have demonstrated success in colorectal, urological, and surgical oncology cases. Patients with a gynecologic oncology diagnosis face an arduous course. Their treatment generally involves a major surgery and is often followed by chemotherapy, radiation, or both.The patient population is generally older in life as the average age for an endometrial or ovarian cancer diagnosis is 63. These patients may already have a lower performance status at baseline deeming their treatment course exponentially more difficult to endure. Women with gynecologic cancer suffer significant mental duress often living in fear of the high rates of recurrence from some of these malignancies suggesting they may benefit from psychologic support and counseling through their treatment. Given the proven success in other surgical disciplines, we believe that instituting prehabilitation programs should be standard of care. Patients will be randomized to a trimodal approach (physical therapy, nutritional counseling, cognitive behavioral therapy) versus a unimodal intervention (physical therapy) for a formal prehabilitation program. Our primary outcome will be functional return to baseline following surgery with secondary outcomes including items such as quality of life assessments, patient satisfaction, and compliance.
Interventions
OTHERUnimodal
Patients will receive physical therapy alone.
OTHERTrimodal
Patients will receive physical therapy, nutrition counseling, and cognitive behavioral therapy in the form of group counseling.
Sponsors
St. Louis University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 90 Years
Healthy volunteers
Yes
Inclusion criteria
* Patient who will be undergoing a planned surgery for known or presumed gynecologic cancer diagnosis.
Exclusion criteria
* Non-English speaking patients * Surgeries done for palliative intent * Poor performance status or other inability to participate in physical therapy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Timed Up and Go | During the approximate 12 week study period | Patients will have a preoperative physical therapy assessment incorporating standard evaluations of a 6 minute walk test, grip strength, and timed up and go. These will serve as the individual patient's baseline for subsequent comparison after surgery. |
| Six Minute Walk Test | During the approximate 12 week study period | Patients will have a preoperative physical therapy assessment incorporating standard evaluations of a 6 minute walk test, grip strength, and timed up and go. These will serve as the individual patient's baseline for subsequent comparison after surgery. |
| Grip Strength | During the approximate 12 week study period | Patients will have a preoperative physical therapy assessment incorporating standard evaluations of a 6 minute walk test, grip strength, and timed up and go. These will serve as the individual patient's baseline for subsequent comparison after surgery. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Readmission Rates | During the 8 weeks after surgery (12 week approximate total study period) | Need for postoperative readmission with be monitored in each group. |
| Complication Rates | During the 12 week approximate total study period | Surgical or treatment complications with be monitored in each group. |
| Patient Satisfaction | At the conclusion of the approximate 12 week study period | Patients from each group will be asked to complete an anonymous survey evaluating their satisfaction with the program. |
| Quality of Life FACT-G Assessment | During the 12 week approximate total study period | Patients will complete baseline and follow up quality of life assessments using the FACT-G (Functional Assessment of Cancer Therapy-General). This is a 28 question quality of life assessment with scores ranging from 0 to 112 (higher scores correlate with a higher quality of life). |
| Treatment Completion | At the conclusion of the 12 week approximate total study period | Rate of program completion will be assessed for each group. |
Countries
United States
Outcome results
None listed